Survey of the effect of vaginal misoprostol on post myomectomy bleeding

Determination of the effect of vaginal misoprostol on post myomectomy bleeding: A double-blind randomized clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220101053581N1

Enrollment

Registered

2022-05-21

Start date

2022-04-09

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine myoma. Leiomyoma of uterus, unspecified

Interventions

Intervention 1: After obtaining permission from the authorities and explanations about the method of intervention to patients and completing the form of demographic questionnaire, patients will be ran

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Myoma less than 8 cm in size on ultrasound married

Exclusion criteria

Exclusion criteria: Contraindications to misoprostol Hemorrhagic disease Active asthma High diastolic blood pressure Recent use of nonsteroidal anti-inflammatory drugs History of severe anemia; Allergies and recent blood transfusions

Design outcomes

Primary

Measure	Time frame
Reduce vaginal bleeding. Timepoint: During surgery and 6 hours after surgery. Method of measurement: Based on suction and gas and long gas.	—

Secondary

Measure	Time frame
Decreased transfusion of blood products. Timepoint: 6 hours after surgery. Method of measurement: Measurement of hemoglobin.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Mazji

Gorgan University of Medical Sciences

m_mazji@yahoo.com+98 17 3220 2173

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026